Few effective options for urinary incontinence

Article

A few nonsurgical treatments for urinary incontinence in women provide modest improvement at best, and expensive drug therapies are really no more effective than pelvic floor muscle and bladder training, say the findings of a systematic review of 96 randomized controlled trials and three systematic reviews published in English from 1990 to 2007.

A few nonsurgical treatments for urinary incontinence in women provide modest improvement at best, and expensive drug therapies are really no more effective than pelvic floor muscle and bladder training, say the findings of a systematic review of 96 randomized controlled trials and three systematic reviews published in English from 1990 to 2007.

The only treatments that really seem to make any difference are pelvic floor muscle training plus bladder training, which, compared with regular care, had a pooled risk difference of 0.13 (95% CI, 0.07 to 0.20), and oxybutynin or tolterodine, which had a pooled risk difference compared with placebo of 0.18 (95% CI, 0.13–0.22). Pelvic floor muscle training alone provided relief or resolution, but did so inconsistently across studies, as did transdermal or vaginal estrogen. Compared with placebo, duloxetine provided improvement (pooled risk difference 0.11; 95% CI, 0.07–0.14), but did not resolve urinary incontinence. Electrical stimulation and adrenergic drugs failed to provide any improvement, and oral hormones actually made urinary incontinence worse.

Shamliyan TA, Kane RL, Wyman J, et al. Systematic review: randomized, controlled trials of nonsurgical treatment for urinary incontinence in women. Ann Intern Med. 2008;148:459-473.

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.